- Correction
- Open access
- Published:
Correction: Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway
Chinese Medicine volume 20, Article number: 20 (2025)
The Original Article was published on 03 January 2025
Correction: Chinese Medicine (2025) 20:2 https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13020-024-01054-1
Following publication of the original article [1], the authors found that the background color of the histograms in panels C, E and F in Fig. 1 is incomplete.
The wrong Fig. 1 was:
Aidi injection inhibits the malignant biological behavior of PC9 and PC9GR cells. A The inhibition of cell viability on PC9 and PC9GR cells by ADI; B the effect of ADI on the formation of PC9 and PC9GR cell colonies; C effect of ADI on the positive rate of EDU cells in PC9 and PC9GR cells (50 μm); D effect of ADI on the wound healing of PC9 and PC9GR cells; E effect of ADI on the migration and invasion of PC9 and PC9GR cells (100 μm); F three-dimensional diagram of the effect of ADI on PC9 and PC9GR cells cycle distribution and effect of ADI on the cell cycle of PC9 and PC9GR cells. *P < 0.05; **P < 0.01
The correct Fig. 1 should be:
Aidi injection inhibits the malignant biological behavior of PC9 and PC9GR cells. A The inhibition of cell viability on PC9 and PC9GR cells by ADI; B the effect of ADI on the formation of PC9 and PC9GR cell colonies; C effect of ADI on the positive rate of EDU cells in PC9 and PC9GR cells (50 μm); D effect of ADI on the wound healing of PC9 and PC9GR cells; E effect of ADI on the migration and invasion of PC9 and PC9GR cells (100 μm); F three-dimensional diagram of the effect of ADI on PC9 and PC9GR cells cycle distribution and effect of ADI on the cell cycle of PC9 and PC9GR cells. *P < 0.05; **P < 0.01
The original article [1] has been updated.
Reference
Zhang J, Yang S, Chen X, et al. Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway. Chin Med. 2025;20:2. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13020-024-01054-1.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, J., Yang, S., Chen, X. et al. Correction: Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway. Chin Med 20, 20 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13020-025-01070-9
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13020-025-01070-9